For instance, in pancreatic cancer, high YY1 expression levels are associated with better clinical outcome for patients (Chen et al., 2019), while in colon cancer YY1 was found to promote tumorigenesis (Fang et al., 2019). Here, YY1 is linked to pancreatic neoplasm.